AIM2 inflammasome activation benefits the therapeutic effect of BCG in bladder carcinoma

• Houhong Zhou,
• Houhong Zhou,
• Lei Zhang,
• Weihan Luo,
• Weihan Luo,
• Huaishan Hong,
• Dongdong Tang,
• Dewang Zhou,
• Lingli Zhou,
• Yuqing Li,
• Yuqing Li

Affiliations

Houhong Zhou

Institute of Urology, The Third Affiliated Hospital of Shenzhen University, Luohu Hospital Group, Shenzhen University, Shenzhen, China

Houhong Zhou

Luohu Clinical Medicine School, Shantou University Medical College, Shantou University, Shantou, China

Lei Zhang

Institute of Urology, The Third Affiliated Hospital of Shenzhen University, Luohu Hospital Group, Shenzhen University, Shenzhen, China

Weihan Luo

Institute of Urology, The Third Affiliated Hospital of Shenzhen University, Luohu Hospital Group, Shenzhen University, Shenzhen, China

Weihan Luo

Luohu Clinical Medicine School, Shantou University Medical College, Shantou University, Shantou, China

Huaishan Hong

Department of Urology, Fujian Provincial Hospital, Fuzhou, Fujian, China

Dongdong Tang

Institute of Urology, The Third Affiliated Hospital of Shenzhen University, Luohu Hospital Group, Shenzhen University, Shenzhen, China

Dewang Zhou

Institute of Urology, The Third Affiliated Hospital of Shenzhen University, Luohu Hospital Group, Shenzhen University, Shenzhen, China

Lingli Zhou

Institute of Urology, The Third Affiliated Hospital of Shenzhen University, Luohu Hospital Group, Shenzhen University, Shenzhen, China

Yuqing Li

Institute of Urology, The Third Affiliated Hospital of Shenzhen University, Luohu Hospital Group, Shenzhen University, Shenzhen, China

Yuqing Li

South China Hospital, Health Science Center, Shenzhen University, Shenzhen, China